Sarcoidosis and autoimmune thyroid disease. A case series of ten patients.

Internal Medicine Service, Institut d'Investigació Biomèdica de Bellvitge, Bellvitge University Hospital, University of Barcelona, Spain.
Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders (Impact Factor: 1.74). 10/2007; 24(2):148-52.
Source: PubMed

ABSTRACT Sarcoidosis coexisting with autoimmune disorders, especially with autoimmune thyroid disease (ATD), has been previously described and a common immunopathogenesis has been proposed. We report a series of ten new cases of this association from a large series of patients with sarcoidosis.
The clinical records of patients diagnosed with sarcoidosis between 1984 and 2006 in the Bellvitge University Hospital were reviewed, and those who were also diagnosed as having ATD were selected. A review of the literature was performed as well.
Ten out of 348 (2.9%) patients with sarcoidosis were identified as having ATD. Sarcoidosis presented as Löfgren's syndrome in 8 patients. Three patients developed Graves' disease, 6 Hashimoto's thyroiditis with hypothyroidism and one had postpartum thyroiditis. In one case, ATD had developed 15 years before sarcoidosis. In the remaining nine cases, sarcoidosis preceded between 4 months to 17 years the development of ATD. In 3 of these cases, sarcoidosis was active when ATD was diagnosed. In one patient, Graves' disease developed immediately after the administration of potassium iodide to treat erythema nodosum.
Sarcoidosis may be associated with ATD at some time of its evolution, either as hyperthyroidism or hypothyroidism. Usually, ATD does not develop during the period of activity of sarcoidosis. We suggest considering personal and family past history of thyroid disease before administering potassium iodide for erythema nodosum in patients with sarcoidosis, as it could trigger hyperthyroidism, especially in patients with iodine deficiency.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To present a case of dysphagia secondary to a progressively increasing non-toxic multinodular goiter caused by sarcoidosis.Methods: We summarize the clinical presentation and pertinent pathology in a patient with sarcoidosis involving the thyroid gland. A review of literature regarding the same is also presented.Results: A 54 year old man was noted to have asymptomatic non-toxic thyromegaly. Biopsy of right thyroid nodule was benign while that from the isthmus nodule was non diagnostic. Two months later he presented with acute onset of dysphagia and work up for gastrointestinal causes was negative. Chest imaging showed left sided lymphadenopathy and biopsy of a lymph node showed sarcoidosis. Two years after the initial presentation a repeat biopsy of the isthmus nodule was again reported as non diagnostic. As he had persisting dysphagia he underwent total thyroidectomy with resolution of dysphagia. Histopathologic examination of the thyroid revealed non necrotizing granulomas consistent with sarcoidosis.Conclusion: This case brings to light this uncommon etiology of a non-toxic multinodular goiter. Involvement of the thyroid gland by sarcoidosis is very rare. It has been reported in 4.2 to 4.6% of patients with sarcoidosis. In patients with pulmonary or extrapulmonary sarcoidosis and associated thyromegaly, possible involvement of the thyroid by this process should be considered.
    Endocrine Practice 01/2013; 19(2):1-12. DOI:10.4158/EP12131.CR · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Minimal-change glomerular disease, sarcoidosis and autoimmune thyroid disease rarely occur in the same patient. We herein report a patient in which minimal-change glomerular disease and Hashimoto’s thyroiditis developed during the treatment of sarcoidosis with steroids. A 66-year-old female was admitted to our hospital with symptoms of nephrotic syndrome. Nine months before admission, she was diagnosed as having ocular and pulmonary sarcoidosis, for which prednisolone at an initial dose of 40 mg/day was started. When the dose of prednisolone was tapered to 20 mg/day, she noticed swelling of the lower extremities. Examination confirmed the simultaneous occurrence of minimal-change glomerular disease and Hashimoto’s thyroiditis, which were diagnosed based on kidney histology, ultrasonography of the thyroid gland and positive antithyroglobulin antibodies. We used intravenous methylprednisolone pulse therapy followed by 40 mg/day oral prednisolone. The patient achieved complete remission of nephrotic syndrome and steroids were tapered without relapse.
    11/2013; 2(2). DOI:10.1007/s13730-013-0072-3
  • Source
    Laboratory Medicine 08/2011; 42(9):516-522. DOI:10.1309/LMU1FTKI76IMJZIQ · 0.49 Impact Factor